NASONEX 24HR ALLERGY FDA approval date

The FDA approved NASONEX 24HR ALLERGY on 17 Mar 2022.

FDA approval date
17 Mar 2022

Drug identity has not yet been verified against registry records

Also recorded as MOMETASONE FUROATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-03-17DayNASONEX 24HR ALLERGYFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215712", "applicant_as_listed_by_fda": "PERRIGO PHARMA INTL", "brand_names": ["NASONEX 24HR ALLERGY"], "active_ingredients": ["MOMETASONE FUROATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220317", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026